EUVIMEDEUVIMED entdecken
Crossref

Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology

Rita Mendes, Bárbara Carreira, Pedro V. Baptista, Alexandra R. Fernandes

Expert Review of Precision Medicine and Drug Development · 2016

DOI: 10.1080/23808993.2016.1159914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Precision Medicine and Drug Development, 2016. Verfasst von Rita Mendes und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 161 Literaturangaben. Gefördert von: Fundação para a Ciěncia e a Tecnologia (FCT/MEC).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the leading cause of cancer-related mortality in the world, non-small lung cancer (NSCLC) is the most frequent subtype (85% of the cases). Within this subtype, adenocarcinoma and squamous cell carcinoma are the most frequent. New therapeutic strategies based on targeted delivery of drugs have relied on the use of biomarkers derived from the patients’ molecular profiling. Several biomarkers have been found to be useful for use as targets for precision therapy in NSCLC, such as mutations in the epidermal growth factor receptor, v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, anaplastic lymphoma kinase, mesenchymal-epithelial transition factor receptor tyrosine kinase, BRAF, c-ros oncogene 1, P53 and phosphatase with tensin homology. Current developments in Nanomedicine have allowed for multifunctional systems capable of delivering therapeutics with increased precision to the target site/tissue, while simultaneously assisting in diagnosis. Here, we review the use of biomarkers in nanotechnology translation in NSCLC management.

Förderung

  • Fundação para a Ciěncia e a Tecnologia (FCT/MEC)

Zitieren

APA

Mendes, R., Carreira, B., Baptista, P. V., & Fernandes, A. R. (2016). Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology. Expert Review of Precision Medicine and Drug Development. https://doi.org/10.1080/23808993.2016.1159914

Vancouver

Mendes R, Carreira B, Baptista PV, Fernandes AR. Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology. Expert Review of Precision Medicine and Drug Development. 2016. doi:10.1080/23808993.2016.1159914

BibTeX
@article{Mendes2016,
  author = {Mendes, Rita and Carreira, Bárbara and Baptista, Pedro V. and Fernandes, Alexandra R.},
  title = {Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology},
  journal = {Expert Review of Precision Medicine and Drug Development},
  year = {2016},
  doi = {10.1080/23808993.2016.1159914}
}
Kostenlos starten →